Radius Health, Inc. (RDUS): Price and Financial Metrics

Radius Health, Inc. (RDUS)

Today's Latest Price: $16.08 USD

0.06 (-0.37%)

Updated Nov 27 1:00pm

Add RDUS to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 240 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

RDUS Stock Summary

  • Radius Health Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than only 4.14% of US listed stocks.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at -2.37 for Radius Health Inc; that's greater than it is for just 4.61% of US stocks.
  • Revenue growth over the past 12 months for Radius Health Inc comes in at 52.24%, a number that bests 90.26% of the US stocks we're tracking.
  • Stocks that are quantitatively similar to RDUS, based on their financial statements, market capitalization, and price volatility, are LJPC, KPTI, VERU, ATNX, and QUIK.
  • Visit RDUS's SEC page to see the company's official filings. To visit the company's web site, go to www.radiuspharm.com.

RDUS Stock Price Chart Interactive Chart >

Price chart for RDUS

RDUS Price/Volume Stats

Current price $16.08 52-week high $23.31
Prev. close $16.14 52-week low $10.15
Day low $15.52 Volume 158,700
Day high $16.27 Avg. volume 582,213
50-day MA $13.62 Dividend yield N/A
200-day MA $13.81 Market Cap 748.48M

Radius Health, Inc. (RDUS) Company Bio

Radius Health is a biopharmaceutical company focused on developing new therapeutics for patients with advanced osteoporosis as well as other serious endocrine-mediated diseases including hormone responsive metastatic breast cancer. The company was founded in 2003 and is based in Waltham, Massachusetts.

RDUS Latest News Stream

Event/Time News Detail
Loading, please wait...

RDUS Latest Social Stream

Loading social stream, please wait...

View Full RDUS Social Stream

Latest RDUS News From Around the Web

Below are the latest news stories about Radius Health Inc that investors may wish to consider to help them evaluate RDUS as an investment opportunity.

Radius Health offloads its final oncology asset

Radius Health (RDUS) down 4% in premarket, has divested its second oncology pipeline asset, RAD140 to Ellipses Pharma, completing Radius’s divestment of its oncology assets.Under the agreement, Ellipses Pharma will take over the clinical development and commercialization of the drug candidate, and Radius will be entitled to receive royalties on the program...

Seeking Alpha | October 1, 2020

The Daily Biotech Pulse: FDA Nod For Pfizer, Sorrento's COVID-19 Antibody Animal Data, Orphazyme's Wall Street Debut

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 28) 10X Genomics Inc (NASDAQ: TXG ) Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) Beigene Ltd (NASDAQ: BGNE ) Cardiff Oncology Inc (NASDAQ: CRDF ) Celldex Therapeutics, Inc. (NASDAQ: CLDX ) Evogene Ltd (NASDAQ: EVGN ) Fate Therapeutics Inc (NASDAQ: FATE ) Guardant Health Inc (NASDAQ: GH ) InVitae Corp (NYSE: NVTA ) Kaleido Biosciences Inc (NASDAQ: KLDO ) Kura Oncology Inc (NASDAQ: KURA ) Lantern Pharma Inc. (NASDAQ: LTRN ) Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA ) Pacific Biosciences of California Inc (NASDAQ: PACB ) Prelude Therapeutics Incorporated (NASDAQ: PRLD ) (listed Thursday) Seattle Genetics, Inc. (NASDAQ: SGEN ) Shockwave Medical Inc...

Benzinga | September 29, 2020

Radius Health & Menarini Group Provide Elacestrant Update

Target enrollment milestone reached in the Phase 3 EMERALD studyLife cycle planning advancing in parallel with current Phase 3 monotherapy program …

GlobeNewswire | September 24, 2020

Radius Health to Participate in the Citi 15th Annual BioPharma Virtual Conference and Morgan Stanley Virtual 18th Annual Global Healthcare Conference

WALTHAM, Mass., Sept. 02, 2020 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS) today announced its participation in the following conferences…

GlobeNewswire | September 2, 2020

Radius Health, Inc. 2020 Q2 - Results - Earnings Call Presentation

The following slide deck was published by Radius Health, Inc. in conjunction with their 2020 Q2 earnings call....

SA Transcripts on Seeking Alpha | August 10, 2020

Read More 'RDUS' Stories Here

RDUS Price Returns

1-mo 19.91%
3-mo 29.89%
6-mo 27.92%
1-year -28.21%
3-year -43.20%
5-year -71.69%
YTD -20.24%
2019 22.26%
2018 -48.10%
2017 -16.46%
2016 -38.20%
2015 58.16%

Continue Researching RDUS

Want to see what other sources are saying about Radius Health Inc's financials and stock price? Try the links below:

Radius Health Inc (RDUS) Stock Price | Nasdaq
Radius Health Inc (RDUS) Stock Quote, History and News - Yahoo Finance
Radius Health Inc (RDUS) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.8207 seconds.